CLPT is trading 5% up at $18.74 as the stock appears to be rebounding following a period of significant price swings.
- The move follows a sharp 8.2% decline on June 30, which came after a 5.1% gain on June 29 and strong performance earlier in the week.
- Investor sentiment remains influenced by a prior 26% surge linked to positive data from partner uniQure’s Huntington’s treatment candidate.
- No fresh company-specific news has emerged today to account for the current upward movement.